vs
Side-by-side financial comparison of Agilent Technologies (A) and CACI INTERNATIONAL INC (CACI). Click either name above to swap in a different company.
CACI INTERNATIONAL INC is the larger business by last-quarter revenue ($2.4B vs $1.8B, roughly 1.3× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 5.5%, a 11.4% gap on every dollar of revenue. On growth, CACI INTERNATIONAL INC posted the faster year-over-year revenue change (8.5% vs 7.0%). CACI INTERNATIONAL INC produced more free cash flow last quarter ($221.4M vs $175.0M). Over the past eight quarters, CACI INTERNATIONAL INC's revenue compounded faster (7.4% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
CACI International Inc is a U.S.-headquartered multinational professional services and information technology firm. It delivers custom technology solutions, cybersecurity services, data analytics, and mission-critical operational support to government defense, intelligence, civilian agencies, and select private sector clients.
A vs CACI — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.8B | $2.4B |
| Net Profit | $305.0M | $130.4M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 9.7% |
| Net Margin | 17.0% | 5.5% |
| Revenue YoY | 7.0% | 8.5% |
| Net Profit YoY | -4.1% | 16.6% |
| EPS (diluted) | $1.07 | $5.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $2.4B | ||
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.7B | $2.3B | ||
| Q2 25 | $1.7B | $2.3B | ||
| Q1 25 | $1.7B | $2.2B | ||
| Q4 24 | $1.7B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.0B |
| Q1 26 | $305.0M | $130.4M | ||
| Q4 25 | $434.0M | $123.9M | ||
| Q3 25 | $336.0M | $124.8M | ||
| Q2 25 | $215.0M | $157.9M | ||
| Q1 25 | $318.0M | $111.9M | ||
| Q4 24 | $351.0M | $109.9M | ||
| Q3 24 | $282.0M | $120.2M | ||
| Q2 24 | $308.0M | $134.7M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | 9.7% | ||
| Q4 25 | 23.8% | 9.3% | ||
| Q3 25 | 20.7% | 9.3% | ||
| Q2 25 | 18.0% | 9.0% | ||
| Q1 25 | 22.4% | 9.1% | ||
| Q4 24 | 24.0% | 8.6% | ||
| Q3 24 | 21.1% | 8.7% | ||
| Q2 24 | 23.1% | 9.7% |
| Q1 26 | 17.0% | 5.5% | ||
| Q4 25 | 23.3% | 5.6% | ||
| Q3 25 | 19.3% | 5.5% | ||
| Q2 25 | 12.9% | 6.9% | ||
| Q1 25 | 18.9% | 5.2% | ||
| Q4 24 | 20.6% | 5.2% | ||
| Q3 24 | 17.9% | 5.8% | ||
| Q2 24 | 19.6% | 6.6% |
| Q1 26 | $1.07 | $5.88 | ||
| Q4 25 | $1.53 | $5.59 | ||
| Q3 25 | $1.18 | $5.63 | ||
| Q2 25 | $0.75 | $7.11 | ||
| Q1 25 | $1.11 | $5.00 | ||
| Q4 24 | $1.23 | $4.88 | ||
| Q3 24 | $0.97 | $5.33 | ||
| Q2 24 | $1.05 | $5.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $158.0M |
| Total DebtLower is stronger | $3.0B | $5.2B |
| Stockholders' EquityBook value | $6.9B | $4.3B |
| Total Assets | $12.8B | $11.6B |
| Debt / EquityLower = less leverage | 0.44× | 1.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $158.0M | ||
| Q4 25 | $1.8B | $423.0M | ||
| Q3 25 | $1.5B | $133.0M | ||
| Q2 25 | $1.5B | $106.2M | ||
| Q1 25 | $1.5B | $223.9M | ||
| Q4 24 | $1.3B | $175.7M | ||
| Q3 24 | $1.8B | $440.7M | ||
| Q2 24 | $1.7B | $134.0M |
| Q1 26 | $3.0B | $5.2B | ||
| Q4 25 | $3.0B | $3.0B | ||
| Q3 25 | $3.4B | $2.8B | ||
| Q2 25 | $3.3B | $2.9B | ||
| Q1 25 | $3.3B | $3.1B | ||
| Q4 24 | $3.3B | $3.1B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.1B | $1.5B |
| Q1 26 | $6.9B | $4.3B | ||
| Q4 25 | $6.7B | $4.1B | ||
| Q3 25 | $6.4B | $4.0B | ||
| Q2 25 | $6.1B | $3.9B | ||
| Q1 25 | $6.0B | $3.7B | ||
| Q4 24 | $5.9B | $3.7B | ||
| Q3 24 | $5.9B | $3.7B | ||
| Q2 24 | $6.2B | $3.5B |
| Q1 26 | $12.8B | $11.6B | ||
| Q4 25 | $12.7B | $8.9B | ||
| Q3 25 | $12.2B | $8.7B | ||
| Q2 25 | $12.2B | $8.6B | ||
| Q1 25 | $11.9B | $8.6B | ||
| Q4 24 | $11.8B | $8.5B | ||
| Q3 24 | $11.0B | $7.2B | ||
| Q2 24 | $10.9B | $6.8B |
| Q1 26 | 0.44× | 1.21× | ||
| Q4 25 | 0.45× | 0.72× | ||
| Q3 25 | 0.53× | 0.69× | ||
| Q2 25 | 0.55× | 0.75× | ||
| Q1 25 | 0.56× | 0.84× | ||
| Q4 24 | 0.57× | 0.82× | ||
| Q3 24 | 0.36× | 0.50× | ||
| Q2 24 | 0.34× | 0.44× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $248.3M |
| Free Cash FlowOCF − Capex | $175.0M | $221.4M |
| FCF MarginFCF / Revenue | 9.7% | 9.4% |
| Capex IntensityCapex / Revenue | 5.2% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.90× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $641.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | $248.3M | ||
| Q4 25 | $545.0M | $154.2M | ||
| Q3 25 | $362.0M | $171.1M | ||
| Q2 25 | $221.0M | $156.0M | ||
| Q1 25 | $431.0M | $230.3M | ||
| Q4 24 | $481.0M | $126.0M | ||
| Q3 24 | $452.0M | $34.7M | ||
| Q2 24 | $333.0M | $157.2M |
| Q1 26 | $175.0M | $221.4M | ||
| Q4 25 | $452.0M | $138.2M | ||
| Q3 25 | $259.0M | $154.1M | ||
| Q2 25 | $107.0M | $128.0M | ||
| Q1 25 | $334.0M | $214.1M | ||
| Q4 24 | $388.0M | $116.1M | ||
| Q3 24 | $360.0M | $23.2M | ||
| Q2 24 | $230.0M | $134.6M |
| Q1 26 | 9.7% | 9.4% | ||
| Q4 25 | 24.3% | 6.2% | ||
| Q3 25 | 14.9% | 6.7% | ||
| Q2 25 | 6.4% | 5.6% | ||
| Q1 25 | 19.9% | 9.9% | ||
| Q4 24 | 22.8% | 5.5% | ||
| Q3 24 | 22.8% | 1.1% | ||
| Q2 24 | 14.6% | 6.6% |
| Q1 26 | 5.2% | 2.5% | ||
| Q4 25 | 5.0% | 0.7% | ||
| Q3 25 | 5.9% | 0.7% | ||
| Q2 25 | 6.8% | 1.2% | ||
| Q1 25 | 5.8% | 0.7% | ||
| Q4 24 | 5.5% | 0.5% | ||
| Q3 24 | 5.8% | 0.6% | ||
| Q2 24 | 6.5% | 1.1% |
| Q1 26 | 0.88× | 1.90× | ||
| Q4 25 | 1.26× | 1.24× | ||
| Q3 25 | 1.08× | 1.37× | ||
| Q2 25 | 1.03× | 0.99× | ||
| Q1 25 | 1.36× | 2.06× | ||
| Q4 24 | 1.37× | 1.15× | ||
| Q3 24 | 1.60× | 0.29× | ||
| Q2 24 | 1.08× | 1.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
CACI
Segment breakdown not available.